Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. - Wikidata - awgldk - TriplyDB

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q46443812

about

PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas Image-guided radiation therapy in lymphoma management Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review Whole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studies Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET Cellular density evaluation for malignant lymphoma using equivalent cross-relaxation rate imaging - initial experience Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma.Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia.F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and concurrent cervical cancer: a case report Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma.FDG-PET/CT in lymphoma.Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.The SUV and FLT PET: a tasty alphabet soup or a dog's breakfast?Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification Imaging and cancer: a review.18F-FDG PET/CT imaging in oncology FDG PET-CT in follicular lymphoma: a case-based evidence review.PET scans as a predictive marker of survival in advanced colorectal cancer.Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT.Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET PET in lymphoma.18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma Initial staging of Hodgkin's disease: role of contrast-enhanced 18F FDG PET/CT Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.Discordant bone marrow involvement in non-Hodgkin lymphoma.The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma PET and PET/CT for response evaluation in lymphoma: current practice and developments.The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.Overview of early response assessment in lymphoma with FDG-PET.Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.PET/CT in oncology: for which tumours is it the reference standard?

P2860

Q26752284-5F9D213D-C10F-49C3-AD19-72096BFA8D58 Q26781339-AE550671-4C37-4DA6-9FD1-402B8032200C Q26801870-B603F3F7-FDAE-499F-95F0-682C87956A3D Q27009240-3EFAB699-B3D8-424B-B033-5997320BDF6A Q27009307-4D75D2B6-B1E3-4FDC-B38B-278E1836F921 Q27015708-5B3393E4-A271-48ED-B90C-8EDABAD4E08F Q27694674-AA159A69-CEAC-4938-8107-1E1A9B3E9451 Q33575972-680398BB-DC67-416D-83A8-CC577CA7ECEA Q33669828-87C816A3-7365-45BE-A224-AE6C026241CB Q33704212-EBD87B1E-3813-4173-B421-4EE3DF3F8ADB Q33919290-1C042442-2BA4-42B1-B82D-46253B19C1B8 Q34009015-8C4306FA-3431-4F4A-A3DB-3F462F672326 Q34105155-A0601BB3-537B-4FE1-9800-1B8760CE4E6B Q34119062-9C31B655-FB49-4B58-B557-EE4320507DC7 Q34408847-4F99198A-BD7E-479B-AE6C-3CE4664C3007 Q34613460-B9FB98AF-7E12-4B86-893D-A38C080C0F83 Q34622215-EDCCA267-B4C0-486E-918E-47E4AA8E6E38 Q34663865-6BCF0FD7-8295-4F5C-95F9-45A5667B39C7 Q34977050-5F08CB4F-369A-48F5-979B-C56248565FD5 Q35006097-3E292AD2-4F46-44B5-81CD-AF08BBF3A227 Q35080079-FB06F825-E86D-4D83-B745-1A1C342A3584 Q35128437-A9D6E93F-EE7E-4737-B08B-9509D0739DAC Q35230789-CCF655B9-883C-4A15-A145-ADB66D7E9B31 Q35377526-CF627816-5030-46CC-8FFF-59748848B29D Q35400919-47425626-FA47-41A6-8335-3C226B165F8F Q35650641-DA593727-5C34-4C27-83FE-DF1F81F42BFE Q35855599-6BDC7D44-D792-4694-8221-30984F54632A Q36150877-70E8F7F2-BBDF-483E-8DB6-F4CEB798B97B Q36344057-1823B49E-E2B2-4118-9083-7FBDA37323F6 Q36429831-513E5E00-341A-4FC9-8CFD-09D85AAE6EE3 Q36622212-DCBF41F6-9933-4D18-BA3F-3BF9A1855D15 Q36663969-10BECED7-BB5B-4B3A-83DC-20C7E74E59D2 Q36746441-6E71B9D5-6D16-4D9C-AB3C-C39563891CB3 Q36805870-CCFF3D41-F8C3-4A96-9107-1567CE3B8FBA Q36838768-0DAD8A79-ABA5-4B17-A9A2-1BAD8204BDE8 Q36869113-F03DBA7E-B754-482A-837D-7BE89BB11A11 Q36911505-0F074B22-7B07-4E37-85D1-B539DE03FEE2 Q36927213-7A378C18-7A62-4D68-90FB-307847669EEA Q36948431-D7D16032-8ABB-4568-BF0C-FC7BCF16F1E2 Q36963748-89AD95E3-2432-4F63-A25A-6F9B7594C984

P2860

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q46443812

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Intensity of 18fluorodeoxygluc ...... essive non-Hodgkin's lymphoma.

@en

Intensity of 18fluorodeoxygluc ...... essive non-Hodgkin's lymphoma.

@nl

type

label

Intensity of 18fluorodeoxygluc ...... essive non-Hodgkin's lymphoma.

@en

Intensity of 18fluorodeoxygluc ...... essive non-Hodgkin's lymphoma.

@nl

prefLabel

Intensity of 18fluorodeoxygluc ...... essive non-Hodgkin's lymphoma.

@en

Intensity of 18fluorodeoxygluc ...... essive non-Hodgkin's lymphoma.

@nl

P1433

Q46443812-58E49B50-E512-4363-B2DA-0D6C2DCD924C

P1476

Q46443812-8705C18A-A0BA-427D-915B-7ACDD7A13969

P2093

Q46443812-13BD1B4F-A7D0-4EFE-B85F-B6F7A80F3813

Q46443812-17764EA0-8B3C-4D71-8E47-BF98BA7F3260

Q46443812-245000FD-8C06-4954-AB81-AF72B4C2E9C0

Q46443812-5858FD9D-BD32-429E-9F4F-8136663552FB

Q46443812-792FE701-6FEB-4599-AEAE-F18F5152A8C5

Q46443812-C8DE4B98-9DC8-431B-B0A5-EEE888B306FD

P304

Q46443812-41CBAC12-7F97-4D39-876A-20E5BAF2A07D

P31

Q46443812-53CC2889-2940-4A12-930B-5FC3CF159951

P356

Q46443812-0BEA8429-DA9A-4E30-8CD3-FDBA02ED8CC0

P407

Q46443812-C3A74F09-3D0B-4CA3-9932-637CFE2495EC

P433

Q46443812-A46A3517-76FD-4A18-A61A-149FC5D1BB60

P478

Q46443812-DD9F79EB-633E-4B01-B23E-820701A6BD3C

P50

Q46443812-1E3B5CF3-F76B-4C26-B288-8E57AF9930E1

Q46443812-AA5EF601-E658-4366-9374-60AD81B80389

P577

Q46443812-505CA001-718D-410A-B08C-6C94979F5C22

P698

Q46443812-EDDCF5C3-8324-485C-B700-D0BA655F3FFE

P356

JCO.2005.12.072

P1433

Journal of Clinical Oncology

P1476

Intensity of 18fluorodeoxygluc ...... ressive non-Hodgkin's lymphoma

@en

P2093

David Green

http://www.w3.org/2001/XMLSchema#string

Heiko Schöder

http://www.w3.org/2001/XMLSchema#string

Henry W D Yeung

http://www.w3.org/2001/XMLSchema#string

Lijun Weng

http://www.w3.org/2001/XMLSchema#string

Mithat Gönen

http://www.w3.org/2001/XMLSchema#string

Steven M Larson

http://www.w3.org/2001/XMLSchema#string

P304

4643-4651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.12.072

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15837966

http://www.w3.org/2001/XMLSchema#string